InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
1
T+90 胜率
50%
T+90 平均收益
-4.6%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Florin Daniel P, 董事. Insider active across 2 companies, notably AtriCure, Inc.. In total, 11 filings have been logged. Breakdown: 3 buys · 1 sell. Total volume traded: €269k. History available since 20 May 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Florin Daniel P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
40,000 股0Common StockSEC:0001402459-26-000002:0
23,321 股@ US$1.9914.8% 占其流量Common StockSEC:0001402459-25-000005:0
23,321 股@ US$3.0627.2% 占其流量Common StockSEC:0001415889-25-015859:0
标准退出：2025年9月3日 (T+90)
37,153 股0Common StockSEC:0001415889-25-015639:0
15,216 股0Common StockSEC:0001415889-24-015640:0
12,620 股0Common StockSEC:0001209191-23-033988:0
5,600 股0Common StockSEC:0001209191-22-034286:0
2,500 股@ US$40.0031.4% 占其流量Common StockSEC:0001209191-21-046602:0
标准退出：2021年10月10日 (T+90)
2,222 股@ US$44.1230.6% 占其流量Common StockSEC:0001209191-21-043518:0
标准退出：2021年9月23日 (T+90)
2,810 股0Common StockSEC:0001209191-21-040068:0
1,749 股0Common StockSEC:0001209191-21-035340:0
11 条申报中的 11 条
About Florin Daniel P
Daniel P. Florin is a Director at AtriCure, Inc. and Pulmonx Corp. In this role, he participates in the governance of the companies and strategic decision-making. Daniel brings expertise in management and business development, helping to guide the policies and practices of the organizations. His commitment to integrity and efficiency is an asset to the boards.
